🔎 Trials Near Me

መነሻ › አልዛይመር በሽታ › Washington

በWashington ለአልዛይመር በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአልዛይመር በሽታ የሚደረጉ 17 ጥናቶች በWashington ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በWashington ውስጥ ያሉ ከተሞች

Official study text (English)

Dominantly Inherited Alzheimer Network (DIAN)

  • University of Washington, Seattle
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT00869817

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Bellevue
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  • Northwest Clinical Research Center, Bellevue
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 1644, Seattle
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06937229

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Northwest Clinical Research Center, Bellevue
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • EvergreenHealth, Kirkland
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  • Northwest Clinical Research Center, Bellevue
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ55 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06847321

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • Local Institution - 1644, Seattle
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • EvergreenHealth Medical Center, Kirkland
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ55 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07011745

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

  • Fred Hutchinson Cancer Center, Seattle
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉለተሳታፊዎች ክፍያ መጠቀስ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT06922188

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • University of Washington Medical Center, Seattle
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of Washington, Seattle
ተሳታዮችን በመፈለግ ላይደረጃ 2/3ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of Washington, Seattle
ተሳታዮችን በመፈለግ ላይደረጃ 2/3ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT06647498

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Northwest Clinical Research Center, Bellevue
  • Universal Research Group, Tacoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • University of Washington Medical Center, Seattle
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT07094516

Late Onset Alzheimer's Disease

  • University of Washington, Seattle
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT05010603

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

  • University of Washington, Seattle
ተሳታዮችን በመፈለግ ላይ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2025 · NCT06411561

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።